Come on in, UK Biobank urges researchers everywhere
This article was originally published in Scrip
Following five years of collecting medical data from some half a million people, UK Biobank is opening its doors to researchers and is keen to emphasise that it wants to be used as widely as possible. The organisation is a not-for-profit charity that aims to facilitate health research in the public interest by offering open access to its resources to scientists across industry and academia both in the UK and overseas.
You may also be interested in...
GlamorousAI is developing technology to uncover new targets and take on previously intractable disease challenges. Founder Noor Shaker hopes to license a drug to big pharma within the next three years.
INFOGRAPHIC: In 2019, 10 blockbuster medicines booked combined sales of $92.5bn. This infographic examines those drugs that commanded the greatest revenues globally, and answers some key questions. Which therapeutic areas include the most lucrative blockbusters? Which companies enjoyed their spoils? And which drugs were new to the top 10 last year? It also takes a look at the position of these products on the all-important US market.
Fundraising in the life sciences sector has been booming even as firms in many other industries are struggling to stay in business. Goodwin’s David Mardle is upbeat about the sector’s ongoing prospects – although M&A deals are currently proving tricky to complete.